India, July 14 -- OneSource Specialty Pharma Ltd. has entered into a strategic manufacturing partnership with Germany-based Formycon AG to support the production of biosimilars for global markets.
Under the agreement, OneSource will serve as Formycon's strategic manufacturing partner, providing integrated drug substance (DS) and drug product (DP) manufacturing services from its biologics manufacturing facility in Bengaluru. The collaboration combines Formycon's biosimilar development expertise with OneSource's end-to-end biologics manufacturing capabilities.
The companies said the partnership aims to strengthen global access to high-quality, affordable biosimilars through reliable, scalable and cost-effective manufacturing. Formycon bring...